Inhibikase Therapeutics
Phase 3We are Inhibikase Therapeutics, a pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial hypertension.
Founded
2008
Focus
Vaccines
About
We are Inhibikase Therapeutics, a pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial hypertension.
Funding History
3Total raised: $30.5M
PIPE$10MUndisclosedDec 15, 2021
IPO$15MUndisclosedOct 7, 2020
Series A$5.5MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2008
LocationAtlanta, United States
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile